JAMIE MITNICK: Open Payments
NPI 1437343084 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 19 payments from 12 companies in 2025. Trend: 2023 $672 · 2024 $1,610 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| bioMerieux Inc | 2 | $173 |
| Optinose US, Inc. | 1 | $127 |
| GlaxoSmithKline, LLC. | 1 | $123 |
| PFIZER INC. | 2 | $112 |
| Novo Nordisk Inc | 4 | $77 |
| Novartis Pharmaceuticals Corporation | 1 | $72 |
| Organon LLC | 1 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $63 |
| Exact Sciences Corporation | 2 | $51 |
| Incyte Corporation | 1 | $35 |
Products named: Xhance, AREXVY, LITFULO, COSENTYX, VTAMA, Kerendia, Wegovy, Opzelura.
Industry payments across FL — which companies pay providers there.
